Emmes

The CRO market has seen tremendous growth in the last 10 years, undergoing significant changes in terms of remote trials, smaller patient populations, as well as the more recent pandemic pressures.   The drug pipeline is also now larger than ever and CROs have increased their strategic importance to innovators – particularly smaller and virtual biotechs. […]